Effects of a caloric restriction weight loss diet and exercise on inflammatory biomarkers in overweight/obese postmenopausal women: a randomized controlled trial

Cancer Research

Volumn 72, Issue 9, 2012, Pages 2314-2326

  Imayama, Ikuyo ^a   Ulrich, Cornelia M ^a,d   Alfano, Catherine M ^e   Wang, Chiachi ^a   Xiao, Liren ^a   Wener, Mark H ^b   Campbell, Kristin L ^f   Duggan, Catherine ^a   Foster Schubert, Karen E ^c   Kong, Angela ^g   Mason, Caitlin E ^a   Wang, Ching Yun ^a,b   Blackburn, George L ^h   Bain, Carolyn E ^a   Thompson, Henry J ⁱ   McTiernan, Anne ^a,b,c  

^a Fred Hutchinson Cancer Research Center   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^d GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^e NATIONAL CANCER INSTITUTE   (United States)

^f UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^g UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^h HARVARD MEDICAL SCHOOL   (United States)

ⁱ Department of Environmental and Radiological Health Sciences   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; C REACTIVE PROTEIN; INTERLEUKIN 6; SERUM AMYLOID A;

ADULT; AEROBIC EXERCISE; ARTICLE; BODY MASS; CALORIC RESTRICTION; CONTROLLED STUDY; FEMALE; HUMAN; INTERMETHOD COMPARISON; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; NEUTROPHIL COUNT; OBESITY; PATIENT COMPLIANCE; PHYSICAL ACTIVITY; POSTMENOPAUSE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; THERAPY EFFECT; TREATMENT OUTCOME; WAIST CIRCUMFERENCE; WEIGHT REDUCTION;

BIOLOGICAL MARKERS; CALORIC RESTRICTION; EXERCISE; FEMALE; HUMANS; INFLAMMATION; INTERLEUKIN-6; LEUKOCYTE COUNT; MIDDLE AGED; NEUTROPHILS; OBESITY; OVERWEIGHT; POSTMENOPAUSE; SERUM AMYLOID A PROTEIN; WEIGHT LOSS;

EID: 84860522779     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-11-3092     Document Type: Article

References (50)

1. McTiernan A. Mechanisms linking physical activity with cancer. Nat Rev Cancer 2008;8:205-11. (Pubitemid 351301840)
2. Hedley AA, Ogden CL, Johnson CL, Carroll MD, Curtin LR, Flegal KM. Prevalence of overweight and obesity among US children, adolescents, and adults, 1999-2002. JAMA 2004;291:2847-50. (Pubitemid 38747805)
3. Crespo CJ, Keteyian SJ, Heath GW, Sempos CT. Leisure-time physical activity among US adults. Results from the Third National Health and Nutrition Examination Survey. Arch Intern Med 1996;156:93-8. (Pubitemid 26011596)
4. Renehan AG, Tyson M, Egger M, Heller RF, Zwahlen M. Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies. Lancet 2008;371:569-78. (Pubitemid 351232031)
5. Fader AN, Arriba LN, Frasure HE, von Gruenigen VE. Endometrial cancer and obesity: epidemiology, biomarkers, prevention and survivorship. Gynecol Oncol 2009;114:121-7.
6. Siegel R, Ward E, Brawley O, Jemal A. Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths. CA Cancer J Clin 2011;61:212-36.
7. Coussens LM, Werb Z. Inflammation and cancer. Nature 2002; 420:860-7. (Pubitemid 36019639)
8. Hussain SP, Harris CC. Inflammation and cancer: an ancient link with novel potentials. Int J Cancer 2007;121:2373-80. (Pubitemid 350022405)
9. Siemes C, Visser LE, Coebergh JW, Splinter TA, Witteman JC, Uitterlinden AG, et al. C-reactive protein levels, variation in the C-reactive protein gene, and cancer risk: the Rotterdam Study. J Clin Oncol 2006;24:5216-22. (Pubitemid 46631365)
10. Tsilidis KK, Branchini C, Guallar E, Helzlsouer KJ, Erlinger TP, Platz EA. C-reactive protein and colorectal cancer risk: a systematic review of prospective studies. Int J Cancer 2008;123:1133-40.
11. Heikkila K, Harris R, Lowe G, Rumley A, Yarnell J, Gallacher J, et al. Associations of circulating C-reactive protein and interleukin-6 with cancer risk: findings from two prospective cohorts and a meta-analysis. Cancer Causes Control 2009;20:15-26.
12. Wang T, Rohan TE, Gunter MJ, Xue X, Wactawski-Wende J, Rajpathak SN, et al.Aprospective study of inflammation markers and endometrial cancer risk in postmenopausal hormone nonusers. Cancer Epidemiol Biomarkers Prev 2011;20:971-7.
13. Dossus L, Rinaldi S, Becker S, Lukanova A, Tjonneland A, Olsen A, et al. Obesity, inflammatory markers, and endometrial cancer risk: a prospective case-control study. Endocr Relat Cancer 2010;17:1007-19.
14. Cuzick J, Otto F, Baron JA, Brown PH, Burn J, Greenwald P, et al. Aspirin and non-steroidal anti-inflammatory drugs for cancer prevention: an international consensus statement. Lancet Oncol 2009;10: 501-7.
15. Genser B, Grammer TB, Stojakovic T, Siekmeier R, Marz W. Effect of HMG CoA reductase inhibitors on low-density lipoprotein cholesterol and C-reactive protein: systematic reviewand meta-analysis. Int J Clin Pharmacol Ther 2008;46:497-510.
16. Baigent C, Blackwell L, Emberson J, Holland LE, Reith C, Bhala N, et al. Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials. Lancet 2010;376:1670-81.
17. Wener MH, Daum PR, McQuillan GM. The influence of age, sex, and race on the upper reference limit of serum C-reactive protein concentration. J Rheumatol 2000;27:2351-9.
18. Lin CY, Chen PC, Kuo HK, Lin LY, Lin JW, Hwang JJ. Effects of obesity, physical activity, and cardiorespiratory fitness on bloodpressure, inflammation, and insulin resistance in the National Health and Nutrition Survey 1999-2002. Nutr Metab Cardiovasc Dis 2010;20:713-9.
19. Lee CG, CarrMC, Murdoch SJ, Mitchell E, Woods NF, Wener MH, et al. Adipokines, inflammation, and visceral adiposity across the menopausal transition: a prospective study. J Clin Endocrinol Metab 2009;94:1104-10.
20. Selvin E, Paynter NP, Erlinger TP. The effect of weight loss on Creactive protein: a systematic review. Arch Intern Med 2007;167:31-9. (Pubitemid 46072404)
21. Nicklas BJ, Ambrosius W, Messier SP, Miller GD, Penninx BW, Loeser RF, et al. Diet-induced weight loss, exercise, and chronic inflammation in older, obese adults: a randomized controlled clinical trial. Am J Clin Nutr 2004;79:544-51. (Pubitemid 41103895)
22. Belalcazar LM, Reboussin DM, Haffner SM, Hoogeveen RC, Kriska AM, Schwenke DC, et al. A 1-year lifestyle intervention for weight loss in individuals with type 2 diabetes reduces high C-reactive protein levels and identifies metabolic predictors of change: from the Look AHEAD (Action for Health in Diabetes) study. Diabetes Care 2010;33:2297-303.
23. Camhi SM, Stefanick ML, Ridker PM, Young DR. Changes in Creactive protein from low-fat diet and/or physical activity in men and women with and without metabolic syndrome. Metabolism 2010;59:54-61.
24. Haffner S, Temprosa M, Crandall J, Fowler S, Goldberg R, Horton E, et al. Intensive lifestyle intervention or metformin on inflammation and coagulation in participants with impaired glucose tolerance. Diabetes 2005;54:1566-72.
25. Esposito K, Pontillo A, Di Palo C, Giugliano G, Masella M, Marfella R, et al. Effect of weight loss and lifestyle changes on vascular inflammatory markers in obese women: a randomized trial. JAMA 2003;289:1799-804. (Pubitemid 37430249)
26. Steensberg A, Keller C, Starkie RL, Osada T, Febbraio MA, Pedersen BK. IL-6 and TNF-alpha expression in, and release from, contracting human skeletal muscle. Am J Physiol Endocrinol Metab 2002;283: E1272-8. (Pubitemid 35340635)
27. Campbell KL, Campbell PT, Ulrich CM, Wener M, Alfano CM, Foster- Schubert K, et al. No reduction in C-reactive protein following a 12- month randomized controlled trial of exercise in men and women. Cancer Epidemiol Biomarkers Prev 2008;17:1714-8.
28. Stewart LK, Earnest CP, Blair SN, Church TS. Effects of different doses of physical activity on C-reactive protein among women. Med Sci Sports Exerc 2010;42:701-7.
29. Church TS, Earnest CP, Thompson AM, Priest EL, Rodarte RQ, Saunders T, et al. Exercise without weight loss does not reduce C-reactive protein: the INFLAME study. Med Sci Sports Exerc 2010;42:708-16.
30. Campbell PT,Campbell KL,WenerMH,Wood BL, Potter JD,McTiernan A, et al. A yearlong exercise intervention decreases CRP among obese postmenopausal women. Med Sci Sports Exerc 2009;41:1533-9.
31. Margolis KL, Rodabough RJ, Thomson CA, Lopez AM, McTiernan A. Prospective study of leukocyte count as a predictor of incident breast, colorectal, endometrial, and lung cancer and mortality in postmenopausal women. Arch Intern Med 2007;167:1837-44. (Pubitemid 47481478)
32. Prasad K. C-reactive protein (CRP)-lowering agents. Cardiovasc Drug Rev 2006;24:33-50. (Pubitemid 46722293)
33. Foster-Schubert KE, Alfano CM, Duggan CR, Xiao L, Campbell KL, Kong A, et al. Effect of diet and exercise, alone or combined, on weight and body composition in overweight-to-obese postmenopausal women. Obesity (Silver Spring). 2011 Apr 4. [Epub ahead of print]
34. Imayama I, Alfano CM, Kong A, Foster-Schubert KE, Bain CE, Xiao L, et al.Dietary weight loss and exercise interventions effects on quality of life in overweight/obese postmenopausal women: a randomized controlled trial. Int J Behav Nutr Phys Act 2011;8:118.
35. Mason C, Foster-Schubert KE, Imayama I, Kong A, Xiao L, Bain C, et al. Dietary weight loss and exercise effects on insulin resistance in postmenopausal women. Am J Prev Med 2011;41:366-75.
36. Mason C, Xiao L, Imayama I, Duggan CR, Bain C, Foster-Schubert KE, et al. Effects of weight loss on serum vitamin D in postmenopausal women. Am J Clin Nutr 2011;94:95-103.
37. Knowler WC, Barrett-Connor E, Fowler SE, Hamman RF, Lachin JM, Walker EA, et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 2002;346: 393-403. (Pubitemid 34437694)
38. Ryan DH, Espeland MA, Foster GD, Haffner SM, Hubbard VS, Johnson KC, et al. Look AHEAD (Action for Health in Diabetes): design and methods for a clinical trial of weight loss for the prevention of cardiovascular disease in type 2 diabetes. Control Clin Trials 2003;24: 610-28. (Pubitemid 38366013)
39. Morgan CR, Lazarow A. Immunoassay of insulin: two-antibody-system. Diabetes 1963;12:115-26.
40. Rubin DB, Schenker N. Multiple imputation for interval estimation from simple random samples with ignorable nonresponse. J Am Stat Assoc 1986;81:366-74.
41. Liang KY, Zeger SL. Longitudinal data analysis using generalized linear models. Biometrika 1986;73:13-22.
42. Blackburn G. Effect of degree of weight loss on health benefits. Obes Res 1995;3 Suppl 2:211s-6s.
43. Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults-The evidence report. National Institutes of Health. Obes Res 1998;6 Suppl 2:51S-209S.
44. Mosca L, Benjamin EJ, Berra K, Bezanson JL, Dolor RJ, Lloyd-Jones DM, et al. Effectiveness-based guidelines for the prevention of cardiovascular disease in women-2011 update: a guideline from the american heart association. Circulation 2011;123:1243-62.
45. Pearson TA, Mensah GA, Alexander RW, Anderson JL, Cannon RO 3rd, Criqui M, et al. Markers of inflammation and cardiovascular disease: application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American heart Association. Circulation 2003;107:499-511. (Pubitemid 36158056)
46. Physical Activity Guidelines Advisory Committee report, 2008. To the secretary of health and human services. Part A: executive summary. Nutr Rev 2009;67:114-20.
47. Kelley GA, Kelley KS. Effects of aerobic exercise on C-reactive protein, body composition, and maximum oxygen consumption in adults: a meta-analysis of randomized controlled trials. Metabolism 2006;55: 1500-7. (Pubitemid 44540369)
48. Brooks N, Layne JE, Gordon PL, Roubenoff R, Nelson ME, Castaneda- Sceppa C. Strength training improves muscle quality and insulin sensitivity in Hispanic older adults with type 2 diabetes. Int J Med Sci 2007;4:19-27. (Pubitemid 46066235)
49. Olson TP, Dengel DR, Leon AS, Schmitz KH. Changes in inflammatory biomarkers following one-year of moderate resistance training in overweight women. Int J Obes (Lond) 2007;31:996-1003. (Pubitemid 46842686)
50. Yoon SS, Dillon CF, Carroll M, Illoh K, Ostchega Y. Effects of statins on serum inflammatory markers: the U.S. National Health and Nutrition Examination Survey 1999-2004. J Atheroscler Thromb 2010;17: 1176-82.